Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity

Molecular Biology of the Cell

Volumn 12, Issue 5, 2001, Pages 1467-1479

  Czekay, R P ^a   Kuemmel, T A ^a   Orlando, R A ^a   Farquhar, M G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL INVASION; CELL MIGRATION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IMMUNOPRECIPITATION; INTERNALIZATION; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; REGULATORY MECHANISM;

ANIMALIA;

EID: 0034756167     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.12.5.1467     Document Type: Article

References (55)

1. A rapid in vitro assay for quantitating the invasive potential of tumor cells
2. The caveolae membrane system
3. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes
4. Clathrin assembly protein AP-2 induces aggregation of membrane vesicles: A possible role for AP-2 in endosome formation
5. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator
6. Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors
7. New fashions in vesicle coats
8. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor
9. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms
10. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells
11. Alpha-2 macroglobulin receptor/LDL receptor-related protein (LRP)-dependent internalization of the urokinase receptor
12. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor
13. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1
14. The expression of megalin and LRP diverges in differentiating F9 embryonal carcinoma cells
15. Endocytic trafficking of megalin/RAP complexes: Dissociation of the complexes in late endosomes
16. Plasminogen activators, tissue degradation, and cancer
17. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule
18. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes
19. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation
20. Surface location and high affinity for calcium of a 500-kD liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor
21. Proteolytic processing of the 600 kD low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment
22. Invasion of reconstituted basement membrane matrix by metastatic human tumor cells
23. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
24. Purification of human plasma alpha 2 macroglobulin and alpha 1 proteinase inhibitor using zinc chelate chromatography
25. 4
26. Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts
27. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae
28. Cell surface dynamics of GPI-anchored proteins
29. Localization of GTPases by indirect immunofluorescence and immunoelectron microscopy
30. The αvβ5 integrin functions as an endocytic receptor for vitronectin
31. 2-macroglobulin receptor as an approximately 440-kDa single chain protein
32. Immunocytochemical identification of the human alpha 2-macroglobulin receptor in monocytes and fibroblasts: Monoclonal antibodies define the receptor as a monocyte differentiation antigen
33. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator
34. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface
35. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator
36. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
37. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor
38. Identification of a cell line that expresses a cell surface and a soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex
39. Functional domains of the receptor-associated protein (RAP)
40. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate
41. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
42. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site
43. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells
44. Dual pathways of internalization of the cholecystokinin receptor
45. Caveolin, a protein component of caveolae membrane coats
46. Cell-associated plasminogen activation: Regulation and physiological functions
47. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits
48. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function
49. Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae)
50. Activation of pro-urokinase and plasminogen on human sarcoma cells: A proteolytic system with surface-bound reactants
51. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
52. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin
53. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview
54. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components
55. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells